GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4675)

  • GC79437 structure
    GC79437SARM1-IN-9
    CAS: 3020765-69-6
    Purity: >98.00%

    SARM1-IN-9 (Compound MY-13B) is a stereoselective SARM1 inhibitor.

  • GC79438 structure
    GC79438Bazlitoran
    CAS: 1378549-07-5
    Purity: >95.00%

    Bazlitoran (IMO-8400) is an oligonucleotide-based TLR7/8/9 antagonist.

  • GC79439 structure
    GC79439Bazlitoran sodium
    CAS: 1613607-40-1
    Purity: >95.00%

    Bazlitoran sodium (IMO-8400 sodium) is an oligonucleotide-based TLR7/8/9 antagonist.

  • GC79440 structure
    GC79440ENDO12
    Purity: >98.00%

    ENDO12 is an inhibitor of the Munc13-4-STX7 protein complex, with a K d value of 2.7 µM for STX7.

  • GC79441 structure
    GC79441Anti-Mouse CD8α Antibody (YTS 105.18)
    Purity: >99.50%

    Anti-Mouse CD8α Antibody (YTS 105.18) is a non-depleting rat IgG2a monoclonal antibody that binds to CD8α on mouse CD8 + T cells.

  • GC79442 structure
    GC79442Anti-CD33 Antibody (OR000283)
    Purity: >99.00%

    Anti-CD33 Antibody (OR000283) (ORM-6151 Antibody; BMS-986497 Antibody) is an antibody targeting CD33.

  • GC79443 structure
    GC79443PY265
    Purity: >95.00%

    PY265 is an anti-human MARCO IgG antibody.

  • GC79444 structure
    GC79444EP 80317 acetate
    Purity: >99.00%

    EP 80317 acetate is a selective CD36 ligand.

  • GC79445 structure
    GC79445AE105
    CAS: 254729-66-3
    Purity: >99.50%

    AE105 is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor ( uPAR ).

  • GC79446 structure
    GC79446EP9
    Purity: >99.50%

    EP9 is a peptide targeting CD63.

  • GC79447 structure
    GC79447FB102
    Purity: >99.00%

    FB102 is an anti-human CD122 (IL-2Rβ) monoclonal antibody with selective activity.

  • GC79448 structure
    GC79448Epoetin alfa
    CAS: 113427-24-0
    Purity: >98.00%

    Epoetin alfa (Epogen) is a recombinant human erythropoietin whose amino acid sequence and biological activity are identical to those of endogenous erythropoietin (EPO).

  • GC79449 structure
    GC79449Lifonebart
    CAS: 3056296-07-9
    Purity: >99.50%

    Lifonebart is a humanized monoclonal antibody targeting TREM2 (triggering receptor expressed on myeloid cells 2).

  • GC79451 structure
    GC79451JP-11646
    CAS: 1902983-63-4
    Purity: >98.50%

    JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 ( IC 50 = 0.5 nM).

  • GC79460 structure
    GC79460MC-Val-Cit-PAB-Amide-TLR7 agonist 4 formic
    Purity: >97.50%

    MC-Val-Cit-PAB-Amide-TLR7 agonist 4 formic (example 15) is a HER2-TLR7 and HER2-TLR8 immune agonist conjugate [1] .

  • GC79463 structure
    GC79463NGI-189
    CAS: 2763063-26-7
    Purity: >99.00%

    NGI‑189 is a selective OST‑A inhibitor.

  • GC79465 structure
    GC79465STAT3-IN-52 hydrochloride
    Purity: >96.00%

    STAT3-IN-52 hydrochloride is an orally active STAT3 inhibitor with a K i value of 2.42 μM.

  • GC79466 structure
    GC79466STAT6-IN-9
    CAS: 3092076-15-5
    Purity: >98.00%

    STAT6-IN-9 is a potent STAT6 inhibitor with an EC 50 value of 4 nM.

  • GC79473 structure
    GC79473AT-051/43421517
    CAS: 1241957-37-8
    Purity: >99.50%

    AT-051/43421517 is a cytoprotective agent and apoptosis inhibitor that binds to human phosphoglycerate kinase 1 ( hPgk1 ).

  • GC79474 structure
    GC79474(E/Z)-ASK1-IN-4
    CAS: 324566-92-9
    Purity: >98.00%

    (E/Z)-ASK1-IN-4 is an isomer of ASK1-IN-4.

  • GC79475 structure
    GC79475MKK7-JNK activator 1
    CAS: 3100092-62-1
    Purity: >99.50%

    MKK7-JNK activator 1 (Compound 10) is a MKK7-JNK pathway activator.

  • GC79476 structure
    GC79476ETC-501
    CAS: 3094990-88-9
    Purity: >97.00%

    ETC-501 is a blood-brain barrier-permeable, orally active, and selective MNK1 / MNK2 inhibitor, with an IC 50 of 0.033 μM against MNK1 and 0.111 μM against MNK2.

  • GC79485 structure
    GC79485Siaresinolic acid
    CAS: 511-77-3
    Purity: >98.00%

    Siaresinolic acid is a compound found in the leaves of Sabicea grisea.

  • GC79486 structure
    GC79486Bacoside A (mixture)
    Purity: >98.00%

    Bacoside A (mixture) is a mixture composed of Bacoside A3, Bacopaside II, Bacopaside X and Bacopasaponin C.